CY1115979T1 - ANTIBODIES AGAINST MYOSTATIN - Google Patents

ANTIBODIES AGAINST MYOSTATIN

Info

Publication number
CY1115979T1
CY1115979T1 CY20151100122T CY151100122T CY1115979T1 CY 1115979 T1 CY1115979 T1 CY 1115979T1 CY 20151100122 T CY20151100122 T CY 20151100122T CY 151100122 T CY151100122 T CY 151100122T CY 1115979 T1 CY1115979 T1 CY 1115979T1
Authority
CY
Cyprus
Prior art keywords
antibodies
antibodies against
against myostatin
myostatin
increasing
Prior art date
Application number
CY20151100122T
Other languages
Greek (el)
Inventor
Julian Davies
Bryan Edward Jones
Andrew Ihor Korytko
Pamela Jean Mitchell
Rosamund Carol Smith
O'BRYAN, (NEE TOBIAS) Linda O
Rong Wang
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06816225.4A external-priority patent/EP1951755B1/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1115979T1 publication Critical patent/CY1115979T1/en

Links

Abstract

Αντισώματα κατά της μυοστατίνης ταυτοποιούνται τα οποία χαρακτηρίζονται ως έχοντα υψηλή συγγένεια και μπορεί να είναι χιμαιρικά, ανθρωποποιημένα ή πλήρως ανθρώπινα αντισώματα, ανοσοσυζεύγματα των αντισωμάτων ή αντιγονοδεσμευτικά θραύσματα αυτών. Τα αντισώματα της εφεύρεσης είναι χρήσιμα για αύξηση της μυϊκής μάζας, αύξηση της οστικής πυκνότητας, ή για την αντιμετώπιση διάφορων διαταραχών σε είδη θηλαστικών και πτηνών.Anti-myostatin antibodies are identified which are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, antibody immunoconjugates or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for treating various disorders in mammalian and avian species.

CY20151100122T 2005-10-12 2015-02-06 ANTIBODIES AGAINST MYOSTATIN CY1115979T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72573805A 2005-10-12 2005-10-12
EP06816225.4A EP1951755B1 (en) 2005-10-12 2006-10-05 Anti-myostatin antibodies

Publications (1)

Publication Number Publication Date
CY1115979T1 true CY1115979T1 (en) 2017-01-25

Family

ID=58457073

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100122T CY1115979T1 (en) 2005-10-12 2015-02-06 ANTIBODIES AGAINST MYOSTATIN

Country Status (1)

Country Link
CY (1) CY1115979T1 (en)

Similar Documents

Publication Publication Date Title
UA92504C2 (en) Anti-myostatin monoclonal antibody
EA200601752A1 (en) ANTIMIOSTATINE ANTIBODIES
CY1120365T1 (en) ANTIBODIES AGAINST IL-17
NO20082073L (en) Anti-myostatin antibodies
CY1113224T1 (en) NEW ANTI-PLLGF ANTIBODY
MX2017006323A (en) Antibodies comprising modified heavy constant regions.
CY1114784T1 (en) ANTIBODIES AGAINST HARDNESS
MX2019013132A (en) Antibodies comprising modified heavy constant regions.
ATE545657T1 (en) TGF-BETA ANTIBODIES
ATE526987T1 (en) DR5 ANTIBODIES AND THEIR USE
CY1116167T1 (en) PHARMACEUTICAL COMPOSITIONS GUIDED ON ERB-B1
DE602006013029D1 (en) ANTI-EGFR ANTIBODY
ATE502052T1 (en) MONOCLONAL ANTIBODIES TO THE HUMAN ANTI-MÜLLERIAN HORMONE RECEPTOR TYPE II (AMHR-II)
ATE530195T1 (en) BISPECIFIC SINGLE CHAIN FV ANTIBODIES MOLECULES AND METHODS OF APPLICATION THEREOF
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
CY1123275T1 (en) BINDING MOLECULES SPECIFICALLY FOR IL-21 AND USES THEREOF
EA202191769A1 (en) TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
CY1115979T1 (en) ANTIBODIES AGAINST MYOSTATIN
EA201992797A1 (en) ANTIBODIES CONTAINING MODIFIED CONSTANT HEAVY CHAIN AREAS
CY1113928T1 (en) ANTI-MYOSTATIN ANTIBODIES
CY1116949T1 (en) M-CSF-SPECIAL monoclonal antibody and its uses
CY1115000T1 (en) HUMAN ANTIBODIES AGAINST RUSSIA AND USE OF THESE
CY1110683T1 (en) ANTI-EGFR ANTIBODIES